Just the Facts on Boston Scientific Corporation (BSX)

Boston Scientific Corporation (BSX) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $30.32, up from yesterday’s close by 1.17%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Boston Scientific Corporation (BSX) currently trades with a market capitalization of $41.74 Billion. That value represents a market adjusting for revenues that have been growing by 10.14 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $1.24 Billion over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0.34 on a per share basis this quarter. Perhaps, that suggests something about why 0.86% of the outstanding share supply is held by institutional investors.

Technical Analysis

Sometimes, we can understand most about a stock by simply looking at how it has been trading. Looking at the stock’s movement on the chart, Boston Scientific Corporation recorded a 52-week high of $30.41. It is now trading 0.09% off that level. The stock is trading $28.50 its 50-day moving average by -1.82%. The stock carved out a 52-week low down at $24.54.

In recent action, Boston Scientific Corporation (BSX) has made a move of +4.95% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 15.08, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.17% with $1.38 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of BSX.

Previous articleThe Case for and Against Discovery (DISCA)
Next articleTaking a Look at the Data Behind The Walt Disney Company (DIS)